EventsThe 1st International Electronic Conference on Pharmaceutics
Published
This submission belongs to the session A. Formulation of Poorly Soluble Drugs of the event The 1st International Electronic Conference on Pharmaceutics
Published date
01 Dec, 2020
Citation
Ana R. M. Ribeiro, Helena P. Felgueiras, Susana P. G. Costa, Sílvia M. M. A Pereira-Lima, Synthesis of Peptaibolin, an antimicrobial peptide, in Proceedings of The 1st International Electronic Conference on Pharmaceutics, 1 December–15 December 2020, MDPI: Basel, Switzerland, doi: 10.3390/IECP2020-08654
Share
Email
Facebook
Twitter
LinkedIn

Synthesis of Peptaibolin, an antimicrobial peptide

image
image
1. Chemistry Research Centre (CQ), University of Minho, Portugal, Portugal
2. Centre for Textile Science and Technology (2C2T), University of Minho, Portugal
3. Chemistry Research Centre (CQ), University of Minho, Portugal
Abstract

To tackle one of the biggest global health problems, the resistance of microorganisms to antibiotics, a collective effort in the search for more effective agents against bacteria was required. Peptides with antimicrobial activity have been rasing much attention as a promising alternative for antibiotics. Peptaibols, for instance, are a family of antimicrobial peptides (AMPs) with great biomedical potential, in which the Peptaibolin can be highlighted. Indeed, this peptide has gained relevance due to its small amino acids content, only four, and its acetyl group and a phenylalaninol residue (Phol) at the N-terminal and C-terminal, respectively. Here, we report the synthesis of Peptaibolin through Solid Phase Peptide Synthesis assisted by Microwave heating (MW-SPPS), in a pre-loaded Phe-Wang resin. Starting from a loading of 0.51 mmol/g, two syntheses were made, using two different combinations of coupling reagents. The best option was DIC/Oxima achieving a yield of 50.0%. Proton Nuclear Magnetic Resonance (1H NMR) studies confirmed the peptide structure, while the High Performance Liquid Chromatography (HPLC) technique verified the peptide purity. To test the solubility of the peptide several combinations of solvents were used and it was found that the peptide was not soluble in water, only in organic solvents or in the combination of both. Antimicrobial testing has been conducted using both Gram-positive (Staphylococcus aureus and Staphylococcus epidermidis) and Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa). Minimum inhibitory concentration studies demonstrated the resistance of bacteria to the peptide action and the peptide instability in bacterial growth conditions.

Keywords
Antimicrobial peptides
peptide synthesis
solid-phase approach
bacteria resistance
Manuscript
Oral Presentation
Poster
Proceeding_RITA_12.11.20_PPT.pdf
Sub-100 nm chitosan-triphosphate-DNA nanoparticles for delivery of DNA vaccines
Ex vivo and In vivo Antiinflammatory Evaluations of Modulated Flavanones Solutions